<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">adair</journal-id><journal-title-group><journal-title xml:lang="ru">Аллергология и Иммунология в Педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Allergology and Immunology in Paediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-1175</issn><issn pub-type="epub">2712-7958</issn><publisher><publisher-name>Ассоциация детских аллергологов и иммунологов России</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53529/2500-1175-2024-1-12-19</article-id><article-id custom-type="elpub" pub-id-type="custom">adair-127</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Влияние обеспеченности организма витамином D на биомаркеры воспаления при бронхиальной астме у детей</article-title><trans-title-group xml:lang="en"><trans-title>The effect of vitamin D provision on biomarkers of inflammation in bronchial asthma in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5533-0205</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белых</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belykh</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Анатольевна Белых, д. м. н., доцент, заведующая кафедрой</p><p>кафедра факультетской и поликлинической педиатрии с курсом педиатрии ФДПО</p><p>390026; ул. Высоковольтная, д. 9; Рязань</p></bio><bio xml:lang="en"><p>Natalia A. Belykh, Dr. Sci., Professor, Head of the Department</p><p>Department of Faculty and Polyclinic Pediatrics with the Course of Pediatrics</p><p>390026; Vysokovoltnaya str., 9; Ryazan</p></bio><email xlink:type="simple">nbelyh68@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9267-439X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пизнюр</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pisnyur</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Инна Владимировна Пизнюр, ассистент</p><p>кафедра факультетской и поликлинической педиатрии с курсом педиатрии ФДПО</p><p>390026; ул. Высоковольтная, д. 9; Рязань</p></bio><bio xml:lang="en"><p>Inna V. Pisnyur, Assistant</p><p>Department of Faculty and Polyclinic Pediatrics with the Course of Pediatrics</p><p>390026; Vysokovoltnaya str., 9; Ryazan</p></bio><email xlink:type="simple">innaabramova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9742-4528</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифоров</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Алексеевич Никифоров, к. м. н., доцент, заведующий лабораторией</p><p>Центральная научно-исследовательская лаборатория</p><p>390026; ул. Высоковольтная, д. 9; Рязань</p></bio><bio xml:lang="en"><p>Aleksandr A. Nikiforov, Cand. Sci., Associate Professor, Head of the Laboratory</p><p>Central Research Laboratory</p><p>390026; Vysokovoltnaya str., 9; Ryazan</p></bio><email xlink:type="simple">a.nikiforov@rzgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6296-9034</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифорова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лариса Владимировна Никифорова, старший научный сотрудник</p><p>Центральная научно-исследовательская лаборатория</p><p>390026; ул. Высоковольтная, д. 9; Рязань</p></bio><bio xml:lang="en"><p>Larisa V. Nikiforova, Senior Researcher</p><p>Central Research Laboratory</p><p>390026; Vysokovoltnaya str., 9; Ryazan</p></bio><email xlink:type="simple">a.nikiforov@rzgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования «Рязанский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Ryazan State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>05</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>12</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Белых Н.А., Пизнюр И.В., Никифоров А.А., Никифорова Л.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Белых Н.А., Пизнюр И.В., Никифоров А.А., Никифорова Л.В.</copyright-holder><copyright-holder xml:lang="en">Belykh N.A., Pisnyur I.V., Nikiforov A.A., Nikiforova L.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://adair.elpub.ru/jour/article/view/127">https://adair.elpub.ru/jour/article/view/127</self-uri><abstract><sec><title>   Актуальность</title><p>   Актуальность. Бронхиальная астма (БА) является широко распространенным в детском возрасте заболеванием и имеет стойкую тенденцию к росту. Поэтому поиск факторов, влияющих на этот процесс, а также биомаркеров, отражающих степень контроля БА, является актуальной проблемой.</p></sec><sec><title>   Цель</title><p>   Цель. Изучить взаимосвязь уровня витамина D с концентрацией периостина и TGF-β1 в сыворотке крови у детей с БА.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. В поперечное (одномоментное) исследование были включены 80 детей в возрасте от 6 до 17 лет (средний возраст — 12 ± 3,2 г.). Обследуемые были распределены на 2 группы: дети с БА — 1-я группа (n = 40); 2-я группа — контрольная группа (n = 40). У всех детей проводили оценку концентрации 25(ОН)D, периостина и TGF-β1 в сыворотке крови.</p></sec><sec><title>   Результаты</title><p>   Результаты. Медиана (Ме) 25(ОН)D витамина D у пациентов с БА была статистически значимо ниже, чем у детей группы сравнения (16,7 нг/мл, против 25,7 нг/мл, p = 0,017), и не зависела от тяжести течения заболевания, соответствовала дефицитному состоянию как при легкой степени (16,2 нг/мл), так и при средней степени тяжести БА (16,8 нг/мл) (p = 0,041). Ме периостина в 1-й группе была в пределах нормы (730,2 нг/мл), но статистически значимо превышала показатель 2-й группы (539,7 нг/мл, р &lt; 0,05) и не зависела от возраста и длительности БА. Высокие показатели периостина имели дети со средней степенью тяжести БА при длительности заболевания 4–6 лет (617,2 нг/мл). Ме TGF-β1 в обеих группах соответствовала нормальным значениям (309,0 и 369,6 пг/мл соответственно, р &gt; 0,05) и не зависела от возраста и длительности БА.</p></sec><sec><title>   Заключение</title><p>   Заключение. В г. Рязани у детей с БА дефицит VD регистрируется в 2 раза чаще, чем у здоровых детей. Показатели периостина в сыворотке крови возрастали пропорционально степени тяжести БА. Дефицит витамина D может выступать одним из факторов риска развития БА и приводить к дисбалансу в системе периостина и TGF-β.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Introduction</title><p>   Introduction. Asthma is a widespread disease in childhood and has a persistent tendency to increase. Therefore, the search for factors influencing this process, as well as biomarkers reflecting the degree of asthma control, is an urgent problem.</p></sec><sec><title>   Objective</title><p>   Objective. To study the relationship of vitamin D levels with the serum periostin and TGF-β1 concentration in children with asthma.</p></sec><sec><title>   Materials and methods</title><p>   Materials and methods. The cross-sectional (one-stage) study included 80 children aged 6 to 17 years (average age — 12 ± 3.2 g). The subjects were divided into 2 groups: children with asthma — group 1 (n = 40); group 2 — the control group (n = 40). In all children, the assessment of the concentration of 25(OH)D, periostin and TGF-β1 in the blood serum was studied.</p></sec><sec><title>   Results</title><p>   Results. Median (Me) 25(OH) in patients with asthma was statistically significantly lower than in children of the comparison group (16.7 ng/ml, versus 25.7 ng/ml, p = 0.017), and did not depend on the severity of the disease, corresponded to a deficiency condition in both mild (16.2 ng/ml) and with an average severity of asthma (16.8 ng/ml) (p = 0.041). Me of periostin in 1st group was within the normal range (730.2 ng/ml), but statistically significantly exceeded the indicator of 2nd group (539.7 ng/ml, p &lt; 0.05) and did not depend on the age and duration of asthma. High rates of periostin were observed in children with moderate severity of asthma with a disease experience of 4–6 years (617.2 ng/ml). Me of TGF-β1 in both groups corresponded to normal values (309.0 and 369.6 pg/ml, respectively, p &gt; 0.05) and did not depend on the age and duration of asthma.</p></sec><sec><title>   Conclusions</title><p>   Conclusions. VD deficiency is registered in children with asthma 2 times more often than in healthy children in Ryazan region. The serum concentration of periostin increased in proportion to the severity of asthma. Vitamin D deficiency can be one of the risk factors for the development of asthma and lead to an imbalance in the periostin and TGF-β system.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>витамин D</kwd><kwd>периостин</kwd><kwd>трансформирующего фактора роста β1</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>asthma</kwd><kwd>vitamin D</kwd><kwd>periostin</kwd><kwd>transforming growth factor β1</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бронхиальная астма: федеральные клинические рекомендации по диагностике и лечению. 2021. 118 с.</mixed-citation><mixed-citation xml:lang="en">Bronchial asthma: federal clinical guidelines for diagnosis and treatment. 2021. 118 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Белых НА, Пизнюр ИВ. Современные представления о роли витамина Д в патогенезе бронхиальной астмы у детей. Наука молодых (Eruditio Juvenium). 2020; 8 (4): 617–628. URL: https://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-roli-vitamina-d-v-patogeneze-bronhialnoy-astmy-u-detey.</mixed-citation><mixed-citation xml:lang="en">Belykh NA, Pisnyur IV. Modern ideas about the role of vitamin D in the pathogenesis of bronchial asthma in children. The Science of the Young (Eruditio Juvenium). 2020; 8 (4): 617–628. (In Russ.)] URL: https://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-roli-vitamina-d-v-patogeneze-bronhialnoy-astmy-u-detey</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Трибунцева ЛВ, Авдеев СН, Будневский АВ, Прозорова ГГ, Кожевникова СА. Сочетанное влияние мультиморбидности и повышенного индекса массы тела на контроль бронхиальной астмы и качество жизни пациентов. Российский медико-биологический вестник им. академика И. П. Павлова. 2023; 31 (1): 37–48. doi: 10.17816/PAVLOVJ111895.</mixed-citation><mixed-citation xml:lang="en">Tribuntseva LV, Avdeev SN, Budnevsky AV, Prozorova GG, Kozhevnikova SA. The combined effect of multimorbidity and an increased body mass index on the control of bronchial asthma and the quality of life of patients. academician I. P. Pavlov. 2023; 31 (1): 37–48. doi: 10.17816/PAVLOVJ111895. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Salmanpour F, Kian N, Samieefar N, et al. Asthma and Vitamin D Deficiency: Occurrence, Immune Mechanisms, and New Perspectives. IJ Immunol Res. 2022; 2022: 1–7. doi: 10.1155/2022/6735900.</mixed-citation><mixed-citation xml:lang="en">Salmanpour F, Kian N, Samieefar N, et al. Asthma and Vitamin D Deficiency: Occurrence, Immune Mechanisms, and New Perspectives. IJ Immunol Res. 2022; 2022: 1–7. doi: 10.1155/2022/6735900.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Izuhara K, Nunomura S, Nanri Y, et al. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019; 74 (11): 2116–2128. doi: 10.1111/all.13814.</mixed-citation><mixed-citation xml:lang="en">Izuhara K, Nunomura S, Nanri Y, et al. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019; 74 (11): 2116–2128. doi: 10.1111/all.13814.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Novosad J, Krčmová I, Bartoš V, et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020; 37 (2): 240–249. doi: 10.5114/ada.2020.94842.</mixed-citation><mixed-citation xml:lang="en">Novosad J, Krčmová I, Bartoš V, et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020; 37 (2): 240–249. doi: 10.5114/ada.2020.94842.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L, Wang J, Liu K. Role of periostin in ECRS. Eur Arch Otorhinolaryngol. 2021; 278 (8): 2665–2672. doi: 10.1007/s00405-020-06369-x.</mixed-citation><mixed-citation xml:lang="en">Yu L, Wang J, Liu K. Role of periostin in ECRS. Eur Arch Otorhinolaryngol. 2021; 278 (8): 2665–2672. doi: 10.1007/s00405-020-06369-x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Turczyn A, Pańczyk-Tomaszewska M. The role of periostin in kidney diseases. Cent Eur J Immunol. 2021; 46 (4): 494–501. doi: 10.5114/ceji.2021.110317.</mixed-citation><mixed-citation xml:lang="en">Turczyn A, Pańczyk-Tomaszewska M. The role of periostin in kidney diseases. Cent Eur J Immunol. 2021; 46 (4): 494–501. doi: 10.5114/ceji.2021.110317.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Alzobaidi N, Rehman S, Naqvi M, Gulati K, Ray A. Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases. J Pharm Pharm Sci. 2022; 25: 137–148. doi: 10.18433/jpps32306.</mixed-citation><mixed-citation xml:lang="en">Alzobaidi N, Rehman S, Naqvi M, Gulati K, Ray A. Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases. J Pharm Pharm Sci. 2022; 25: 137–148. doi: 10.18433/jpps32306.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Потапова НЛ, Гаймоленко ИН. Анализ уровня трансформирующего фактора роста Β1 у детей, больных бронхиальной астмой. Мать и дитя в Кузбассе. 2019; 4 (79): 21–25.</mixed-citation><mixed-citation xml:lang="en">Potapova NL, Gaimolenko IN. Analysis of the level of transforming growth factor Β1 in children with bronchial asthma. Mother and child in Kuzbass. 2019; 4 (79): 21–25. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rozmus D, Ciesielska A, Płomiński J, et al. Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases. Int J Mol Sci. 2020; 21 (21): 7822 doi: 10.3390/ijms21217822.</mixed-citation><mixed-citation xml:lang="en">Rozmus D, Ciesielska A, Płomiński J, et al. Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases. Int J Mol Sci. 2020; 21 (21): 7822 doi: 10.3390/ijms21217822.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li Q, Zhou Q, Zhang G. et al. Vitamin D Supplementation and Allergic Diseases during Childhood: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14 (19): 3947. doi: 10.3390/nu14193947.</mixed-citation><mixed-citation xml:lang="en">Li Q, Zhou Q, Zhang G. et al. Vitamin D Supplementation and Allergic Diseases during Childhood: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14 (19): 3947. doi: 10.3390/nu14193947.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Williamson A, Martineau AR, Sheikh A, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2023; 6 (2): CD011511. doi: 10.1002/14651858.CD011511.pub3.</mixed-citation><mixed-citation xml:lang="en">Williamson A, Martineau AR, Sheikh A, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2023; 6 (2): CD011511. doi: 10.1002/14651858.CD011511.pub3.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Esfandiar N, Alaei F, Fallah S, et al. Vitamin D deficiency and its impact on asthma severity in asthmatic children. Ital J Pediatr. 2016; 42 (1): 108. doi: 10.1186/s13052-016-0300-5.</mixed-citation><mixed-citation xml:lang="en">Esfandiar N, Alaei F, Fallah S, et al. Vitamin D deficiency and its impact on asthma severity in asthmatic children. Ital J Pediatr. 2016; 42 (1): 108. doi: 10.1186/s13052-016-0300-5.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Costa Dias Ladeira JM, Zacas O, Ferreira AM. et al. The role of vitamin D in the severity and control of asthma in children and adolescents: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101 (50): e31457. doi: 10.1097/MD.0000000000031457.</mixed-citation><mixed-citation xml:lang="en">Costa Dias Ladeira JM, Zacas O, Ferreira AM. et al. The role of vitamin D in the severity and control of asthma in children and adolescents: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022; 101 (50): e31457. doi: 10.1097/MD.0000000000031457.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Global Strategy for Asthma Management and Prevention. Updated 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf</mixed-citation><mixed-citation xml:lang="en">Global Strategy for Asthma Management and Prevention. Updated 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Боровик ТЕ, Громова ОА, Захарова ВВ, Мальцев СВ, Мошетова ЛК, Намазова-Баранова ЛС и др. Недостаточность витамина D у детей и подростков Российской Федерации: современные подходы к коррекции. Национальная программа. Москва. Издательский дом «Педиатр», 2021. 116 с.</mixed-citation><mixed-citation xml:lang="en">Borovik TE, Gromova OA, Zakharova VV, Maltsev SV, Moshetova LK, Namazova-Baranova LS, etc. Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction. The national program. Moscow. Publishing house «Pediatrician», 2021. 116 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Калашникова ЛА, Данилова МС, Шабалина АА. и др. Трансформирующий фактор роста бета у больных с диссекцией внутренних сонных и позвоночных артерий. Журнал неврологии и психиатрии им. С. С. Корсакова 2022; 122 (10): 82–87. doi: 10.17116/jnevro202212210182</mixed-citation><mixed-citation xml:lang="en">Kalashnikova LA, Danilova MS, Shabalina AA et al. Transforming growth factor beta in patients with dissection of internal carotid and vertebral arteries. Journal of Neurology and Psychiatry named after S. S. Korsakov. 2022; 122 (10): 82–87. doi: 10.17116/jnevro202212210182. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Q, Ying Q, Zhu W, et al. Vitamin D and asthma occurrence in children : A systematic review and meta-analysis. J Pediatr Nurs. 2022; e60–e68. doi: 10.1016/j.pedn.2021.07.005.</mixed-citation><mixed-citation xml:lang="en">Wang Q, Ying Q, Zhu W, et al. Vitamin D and asthma occurrence in children : A systematic review and meta-analysis. J Pediatr Nurs. 2022; e60–e68. doi: 10.1016/j.pedn.2021.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Масальский СС, Калмыкова АС, Уханова ОП. Особенности обеспеченности витамином D при различном клиническом течении бронхиальной астмы у детей и подростков. Аллергология и иммунология в педиатрии. 2018; 1 (52): 25–32.</mixed-citation><mixed-citation xml:lang="en">Masalskiy SS, Kalmykova AS, Ukhanova OP. Features of vitamin D provision in various clinical course of bronchial asthma in children and adolescents. Allergology and immunology in pediatrics. 2018; 1 (52): 25–32. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue T, Akashi K, Watanabe M, et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016; 27 (5): 521–526. doi: 10.1111/pai.12575.</mixed-citation><mixed-citation xml:lang="en">Inoue T, Akashi K, Watanabe M, et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016; 27 (5): 521–526. doi: 10.1111/pai.12575.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Song JS, You JS, Jeong SI, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70 (6): 674–681. doi: 10.1111/all.12599.</mixed-citation><mixed-citation xml:lang="en">Song JS, You JS, Jeong SI, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70 (6): 674–681. doi: 10.1111/all.12599.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yavuz ST, Bagci S, Bolat A, et al. Association of serum periostin levels with clinical features in children with asthma. Pediatr Allergy Immunol. 2021; 32 (5): 937–944. doi: 10.1111/pai.13444.</mixed-citation><mixed-citation xml:lang="en">Yavuz ST, Bagci S, Bolat A, et al. Association of serum periostin levels with clinical features in children with asthma. Pediatr Allergy Immunol. 2021; 32 (5): 937–944. doi: 10.1111/pai.13444.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Масальский СС, Калмыкова АС, Уханова ОП. Комплексная оценка сывороточного периостина — нового маркера аллергического воспаления при неконтролируемой БА у детей. Российский Аллергологический Журнал. 2018; 15 (1S): 55–57. URL: https://elibrary.ru/item.asp?id=36409805.</mixed-citation><mixed-citation xml:lang="en">Masalskiy SS, Kalmykova AS, Ukhanova OP. Сomplex evaluation of serum periostin — new marker of allergic inflammation at uncontrolled bronchial asthma at children. Russian Journal of Allergy. 2018; 15 (1S): 55–57. URL: https://elibrary.ru/item.asp?id=36409805. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
